The latest quarterly performance of Canopy Growth Corporation (NYSE: CGC) was nothing short of a disaster, with the cannabis firm incurring a
With right product mix and CAPEX discipline, Canopy Growth (CGC) can hit growth path
Categories
Cannabis
Infographic: Highlights of Canopy Growth (CGC) Q4 2020 earnings results
Canopy Growth Corporation (NYSE: CGC) reported its financial results for the quarter ended March 31, 2020, on Friday before the market opens.
Village Farms (VFF): Regulatory uncertainty – a major roadblock for US CBD opportunity
Village Farms International Inc. (NASDAQ: VFF) reported total sales of $39.6 million for the first quarter of 2020 compared to $38.6 million
Infographic: Highlights of Aurora Cannabis (ACB) Q3 2020 Earnings Report
Aurora Cannabis, Inc. (NYSE: ACB) reported a narrower loss for the third quarter of 2020, aided by a 16% growth in revenues.
Arcadia Biosciences (RKDA): GoodHemp forms key part of growth strategy
Arcadia Biosciences (NASDAQ: RKDA) saw its revenues nearly double to $309,000 in the first quarter of 2020 versus the same period a
Tilray’s (TLRY) loss widens in Q1 despite minimal impact from COVID-19
Tilray (NASDAQ: TLRY) reported mixed results yesterday for its first quarter of 2020. Despite revenue rising more than 100% in the quarter,
GW Pharmaceuticals (GWPH): Investments in manufacturing and international expansion serve as strong growth drivers
GW Pharmaceuticals plc (NASDAQ: GWPH) has seen its stock gain over 17% in the past one month. The company delivered topline growth
Tilray Inc (NASDAQ: TLRY) Q1 2020 Earnings Call Transcript
Tilray Inc (TLRY) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive Officer Michael Kruteck -- Chief
GW Pharmaceuticals PLC (NASDAQ: GWPH) Q1 2020 Earnings Call Transcript
GW Pharmaceuticals PLC (GWPH) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Stephen Schultz -- Vice President, Investor Relations Justin Gover -- Chief Executive
New products, global expansion might help Cronos Group beat Covid crisis
The cannabis market, which has been witnessing issues like low demand and the vaping crisis, is probably headed for a slowdown this
Cronos Group Inc. (NASDAQ: CRON) Q1 2020 Earnings Call Transcript
Cronos Group Inc. (CRON) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Shayne Laidlaw -- Investor Relations Mike Gorenstein -- Chairman, President and Chief
Cronos Group (CRON) Q1 profit dips 76% amid continued growth of cannabis
Cronos Group Inc. (NASDAQ: CRON) reported a 76% dip in earnings for the first quarter of 2020 due to higher operating expenses
Aphria Inc (NYSE: APHA) Q3 2020 Earnings Call Transcript
Aphria Inc (APHA) Q3 2020 earnings call dated Apr. 15, 2020 Corporate Participants: Katie M. Turner -- Investor Relations Irwin D. Simon -- Chief Executive Officer Carl
Village Farms International Inc. (NASDAQ:VFF) Q4 2019 Earnings Call Transcript
Village Farms International Inc. (NASDAQ: VFF) Q4 2019 Earnings Conference Call Mar. 31, 2020 Corporate Participants: Michael A. DeGiglio -- President & Chief Executive Officer
Aphria Inc (NYSE: APHA) Q2 2020 Earnings Call Transcript
Aphria Inc (NYSE: APHA) Q2 2020 Earnings Conference Call January 14, 2020 Corporate Participants: Katie M. Turner -- Managing Director Irwin D. Simon -- Interim Chief Executive
HEXO Corp. (NYSE: HEXO) Q2 2020 Earnings Call Transcript
HEXO Corp. (NYSE: HEXO) Q2 2020 Earnings Conference Call Mar. 30, 2020 Corporate Participants: Jennifer Smith -- Director, Investor Relations Sebastien St-Louis -- Co-Founder and Chief Executive
Cronos Group Inc. (NASDAQ: CRON) Q4 2019 Earnings Call Transcript
Cronos Group Inc. (NASDAQ: CRON) Q4 2019 Earnings Conference Call Mar. 30, 2020 Corporate Participants: Anna Shlimak -- Investor Relations Mike Gorenstein -- Chairman, President and Chief
Cronos Group (CRON) swings to a profit in Q4
Cronos Group Inc. (NASDAQ: CRON) swung to a profit in the fourth quarter of 2019 from a loss last year, helped by
HEXO Corp (HEXO) loss in Q2 widens amid impairment charges
HEXO Corp.'s (TSX: HEXO; NYSE: HEXO) loss expanded in the second quarter of 2020, hurt by significant impairment charges. Hexo posted a
Arcadia Biosciences (RKDA) reports a wider loss in Q4 2019
Arcadia Biosciences' (NASDAQ: RKDA) loss expanded, while revenue dropped in the fourth quarter of 2019. The agricultural food ingredient company posted a
Aurora Cannabis Inc (NYSE: ACB) Q2 2020 Earnings Call Transcript
Aurora Cannabis Inc (NYSE: ACB) Q2 2020 Earnings Conference Call February 13, 2020 Corporate Participants: Michael Singer -- Interim Chief Executive Officer and Executive